EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Depression and Its Phytopharmacotherapy—A Narrative Review

Lukasz Dobrek iD, Krystyna Głowacka

International Journal of Molecular Sciences · 01.03.2023 · 24 (5) · 4772

DOI: 10.3390/ijms24054772 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.03.2023. Verfasst von Lukasz Dobrek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Wroclaw Medical University, 50-556 Wroclaw, Poland. Hauptthemen laut MEDLINE: Depressive Disorder, Hypericum. Die Arbeit wurde bisher 140-mal zitiert (Crossref) und nennt 272 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is a mental health disorder that develops as a result of complex psycho-neuro-immuno-endocrinological disturbances. This disease presents with mood disturbances, persistent sadness, loss of interest and impaired cognition, which causes distress to the patient and significantly affects the ability to function and have a satisfying family, social and professional life. Depression requires comprehensive management, including pharmacological treatment. Because pharmacotherapy of depression is a long-term process associated with the risk of numerous adverse drug effects, much attention is paid to alternative therapy methods, including phytopharmacotherapy, especially in treating mild or moderate depression. Preclinical studies and previous clinical studies confirm the antidepressant activity of active compounds in plants, such as St. John’s wort, saffron crocus, lemon balm and lavender, or less known in European ethnopharmacology, roseroot, ginkgo, Korean ginseng, borage, brahmi, mimosa tree and magnolia bark. The active compounds in these plants exert antidepressive effects in similar mechanisms to those found in synthetic antidepressants. The description of phytopharmacodynamics includes inhibiting monoamine reuptake and monoamine oxidase activity and complex, agonistic or antagonistic effects on multiple central nervous system (CNS) receptors. Moreover, it is noteworthy that the anti-inflammatory effect is also important to the antidepressant activity of the plants mentioned above in light of the hypothesis that immunological disorders of the CNS are a significant pathogenetic factor of depression. This narrative review results from a traditional, non-systematic literature review. It briefly discusses the pathophysiology, symptomatology and treatment of depression, with a particular focus on the role of phytopharmacology in its treatment. It provides the mechanisms of action revealed in experimental studies of active ingredients isolated from herbal antidepressants and presents the results of selected clinical studies confirming their antidepressant effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Depressive DisorderHypericumHumansDepressionPhytotherapyAntidepressive Agents

Stichwörter der Autor:innen

antidepressantdepressionherbalmedicinal plantstreatment

Substanzen

Antidepressive Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Wroclaw Medical University, 50-556 Wroclaw, Poland.

ORCID-Profile: Lukasz Dobrek

Zitieren

APA

Dobrek, L., & Głowacka, K. (2023). Depression and Its Phytopharmacotherapy—A Narrative Review. International Journal of Molecular Sciences, 24(5), 4772. https://doi.org/10.3390/ijms24054772

Vancouver

Dobrek L, Głowacka K. Depression and Its Phytopharmacotherapy—A Narrative Review. International Journal of Molecular Sciences. 2023;24(5):4772. doi:10.3390/ijms24054772

BibTeX
@article{Dobrek2023,
  author = {Dobrek, Lukasz and Głowacka, Krystyna},
  title = {Depression and Its Phytopharmacotherapy—A Narrative Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {5},
  pages = {4772},
  doi = {10.3390/ijms24054772}
}
Kostenlos starten →